Patents by Inventor Gordon B. Bishop

Gordon B. Bishop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11931262
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium, through the mitral valve, and into the left ventricle. A ventricular anchor is deployed from the catheter and into a wall of the left ventricle, leaving a ventricular suture attached to the ventricular anchor and extending proximally through the catheter. A leaflet anchor is deployed to secure a mitral valve leaflet to a leaflet suture, with the leaflet suture extending proximally through the catheter. The leaflet suture is secured to the ventricular suture to limit a range of travel of the leaflet in the direction of the left atrium. Also disclosed is an assembled in situ mitral valve leaflet restraint, having a neo papillary muscle and a neo chordae tendinea.
    Type: Grant
    Filed: January 20, 2021
    Date of Patent: March 19, 2024
    Assignee: Pipeline Medical Technologies, Inc.
    Inventors: Gordon B. Bishop, Randall T. Lashinski, Erik Griswold
  • Publication number: 20230404756
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium. From an atrium side, a leaflet connector carried by a distal end of the catheter can be anchored to a superior surface of a mitral valve leaflet. A needle is axially advanceable through the leaflet connector and through the leaflet. A leaflet anchor having a leaflet suture can be advanced out of the needle to secure the mitral valve leaflet to the leaflet suture. A ventricular anchor is anchored to the wall of the ventricle to secure the ventricular wall to a ventricle suture. The leaflet suture and the ventricle suture may be tensioned and connected by a suture lock to form an artificial chordae.
    Type: Application
    Filed: May 23, 2023
    Publication date: December 21, 2023
    Inventors: Trung Ho Pham, Gordon B. Bishop, Erik Griswold, Stephen McDaniel, Cameron Paul Purcell
  • Publication number: 20230380969
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium. From an atrium side, the catheter can be anchored to a superior surface of a mitral valve leaflet and a leaflet anchor can be advanced into the mitral valve leaflet to secure the mitral valve leaflet to a leaflet suture. A ventricular anchor is anchored to the wall of the ventricle to secure the ventricular wall to a ventricle suture. The leaflet suture and the ventricle suture may be tensioned and connected by a suture lock to form an artificial chordae.
    Type: Application
    Filed: May 22, 2023
    Publication date: November 30, 2023
    Inventors: Gordon B. Bishop, Erik Griswold, Stephen R. McDaniel, Trung H. Pham, Cameron P. Purcell, Hien N. Lam
  • Publication number: 20230363909
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium, through the mitral valve, and into the left ventricle. A ventricular anchor is deployed from the catheter and into a wall of the left ventricle, leaving a ventricular suture attached to the ventricular anchor and extending proximally through the catheter. A leaflet anchor is deployed to secure a mitral valve leaflet to a leaflet suture, with the leaflet suture extending proximally through the catheter. The leaflet suture is secured to the ventricular suture to limit a range of travel of the leaflet in the direction of the left atrium. Also disclosed is an assembled in situ mitral valve leaflet restraint, having a neo papillary muscle and a neo chordae tendinea.
    Type: Application
    Filed: May 15, 2023
    Publication date: November 16, 2023
    Inventors: Gordon B. Bishop, Randall T. Lashinski
  • Publication number: 20230320855
    Abstract: A delivery system and a method for deploying a cardiovascular prosthetic implant using a minimally invasive procedure are disclosed. The delivery system comprises an introducer catheter, a delivery catheter having a proximal end and a distal end, and a seal assembly, wherein an outer diameter of the distal end of the delivery catheter is greater than an inner diameter of the distal end of the introducer catheter.
    Type: Application
    Filed: May 22, 2023
    Publication date: October 12, 2023
    Inventors: Gordon B. Bishop, Kevin C. Robin
  • Publication number: 20230225865
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium. From an atrium side, the catheter can be anchored to a superior surface of a mitral valve leaflet and a leaflet anchor can be advanced into the mitral valve leaflet to secure the mitral valve leaflet to a leaflet suture. A ventricular anchor is anchored to the wall of the ventricle to secure the ventricular wall to a ventricle suture. The leaflet suture and the ventricle suture may be tensioned and connected by a suture lock to form an artificial chordae.
    Type: Application
    Filed: June 2, 2021
    Publication date: July 20, 2023
    Inventors: Cameron Paul Purcell, Gordon B. Bishop, Trung Ho Pham, Stephen R. McDaniel, Hien Ngoc Lam, Whittaker Ian Hamill, Katie Nicole Riojas
  • Patent number: 11696828
    Abstract: Methods and devices for transvascular prosthetic chordae tendinae implantation are disclosed. A catheter is advanced into the left atrium. From an atrium side, the catheter can be anchored to a superior surface of a mitral valve leaflet and a leaflet anchor can be advanced into the mitral valve leaflet to secure the mitral valve leaflet to a leaflet suture. A ventricular anchor is anchored to the wall of the ventricle to secure the ventricular wall to a ventricle suture. The leaflet suture and the ventricle suture may be tensioned and connected by a suture lock to form an artificial chordae.
    Type: Grant
    Filed: December 11, 2019
    Date of Patent: July 11, 2023
    Assignee: Pipeline Medical Technologies, Inc.
    Inventors: Gordon B. Bishop, Erik Griswold, Stephen R. McDaniel, Trung H. Pham, Cameron P. Purcell, Hien N. Lam
  • Patent number: 11690719
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium. From an atrium side, a leaflet connector carried by a distal end of the catheter can be anchored to a superior surface of a mitral valve leaflet. A needle is axially advanceable through the leaflet connector and through the leaflet. A leaflet anchor having a leaflet suture can be advanced out of the needle to secure the mitral valve leaflet to the leaflet suture. A ventricular anchor is anchored to the wall of the ventricle to secure the ventricular wall to a ventricle suture. The leaflet suture and the ventricle suture may be tensioned and connected by a suture lock to form an artificial chordae.
    Type: Grant
    Filed: May 21, 2020
    Date of Patent: July 4, 2023
    Assignee: Pipeline Medical Technologies, Inc.
    Inventors: Trung Ho Pham, Gordon B. Bishop, Erik Griswold, Stephen McDaniel, Cameron Paul Purcell
  • Patent number: 11684475
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium, through the mitral valve, and into the left ventricle. A ventricular anchor is deployed from the catheter and into a wall of the left ventricle, leaving a ventricular suture attached to the ventricular anchor and extending proximally through the catheter. A leaflet anchor is deployed to secure a mitral valve leaflet to a leaflet suture, with the leaflet suture extending proximally through the catheter. The leaflet suture is secured to the ventricular suture to limit a range of travel of the leaflet in the direction of the left atrium. Also disclosed is an assembled in situ mitral valve leaflet restraint, having a neo papillary muscle and a neo chordae tendinea.
    Type: Grant
    Filed: May 22, 2020
    Date of Patent: June 27, 2023
    Assignee: Pipeline Medical Technologies, Inc.
    Inventors: Gordon B. Bishop, Randall T. Lashinski
  • Patent number: 11666441
    Abstract: Methods and devices for transvascular prosthetic chordae tendineae implantation are disclosed. A catheter is advanced into the left atrium. From an atrium side, a leaflet anchor having a leaflet suture is secured to the mitral valve leaflet. A ventricular anchor is anchored to the wall of the ventricle to secure the ventricular wall to a ventricle suture. The leaflet suture and the ventricle suture may be tensioned and connected by a suture lock to form an artificial chordae. The suture lock has a body with a suture path extending therethrough. A wall in the housing is movable to reduce the cross section of the suture path. A drive mechanism advances the movable wall to clamp sutures extending through the suture path, in response to rotation of a coupling on the housing.
    Type: Grant
    Filed: July 11, 2019
    Date of Patent: June 6, 2023
    Assignee: Pipeline Medical Technologies, Inc.
    Inventors: Stephen McDaniel, Gordon B. Bishop, Erik Griswold, Trung Ho Pham, Cameron Paul Purcell
  • Publication number: 20220265424
    Abstract: A delivery system and a method for deploying a cardiovascular prosthetic implant using a minimally invasive procedure are disclosed. The delivery system comprises an introducer catheter, a delivery catheter having a proximal end and a distal end, and a seal assembly, wherein an outer diameter of the distal end of the delivery catheter is greater than an inner diameter of the distal end of the introducer catheter.
    Type: Application
    Filed: September 30, 2021
    Publication date: August 25, 2022
    Inventors: Gordon B. Bishop, Kevin C. Robin
  • Publication number: 20220125582
    Abstract: An implantable prosthetic valve has an in situ formable support structure. The valve comprises a prosthetic valve, having a base and at least one flow occluder. A first flexible component is incapable of retaining the valve at a functional site in the arterial vasculature. The first component extends proximally of the base of the valve. A second flexible component is incapable of retaining the valve at a functional site in the arterial vasculature. The second component extends distally of the base of the valve. At least one rigidity component combines with at least one of the first and second flexible components to impart sufficient rigidity to the first or second components to retain the valve at the site.
    Type: Application
    Filed: December 15, 2021
    Publication date: April 28, 2022
    Applicant: Speyside Medical, LLC
    Inventors: Randall T. Lashinski, Gordon B. Bishop
  • Patent number: 11083580
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium. From an atrium side, the catheter can be anchored to a superior surface of a mitral valve leaflet and a leaflet anchor can be advanced into the mitral valve leaflet to secure the mitral valve leaflet to a leaflet suture. A ventricular anchor is anchored to the wall of the ventricle to secure the ventricular wall to a ventricle suture. The leaflet suture and the ventricle suture may be tensioned and connected by a suture lock to form an artificial chordae.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: August 10, 2021
    Assignee: Pipeline Medical Technologies, Inc.
    Inventors: Cameron Paul Purcell, Erik Griswold, Gordon B. Bishop, Stephen McDaniel, Trung Ho Pham
  • Publication number: 20210186699
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium, through the mitral valve, and into the left ventricle. A ventricular anchor is deployed from the catheter and into a wall of the left ventricle, leaving a ventricular suture attached to the ventricular anchor and extending proximally through the catheter. A leaflet anchor is deployed to secure a mitral valve leaflet to a leaflet suture, with the leaflet suture extending proximally through the catheter. The leaflet suture is secured to the ventricular suture to limit a range of travel of the leaflet in the direction of the left atrium. Also disclosed is an assembled in situ mitral valve leaflet restraint, having a neo papillary muscle and a neo chordae tendinea.
    Type: Application
    Filed: January 20, 2021
    Publication date: June 24, 2021
    Inventors: Gordon B. Bishop, Randall T. Lashinski, Erik Griswold
  • Patent number: 10925731
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium, through the mitral valve, and into the left ventricle. A ventricular anchor is deployed from the catheter and into a wall of the left ventricle, leaving a ventricular suture attached to the ventricular anchor and extending proximally through the catheter. A leaflet anchor is deployed to secure a mitral valve leaflet to a leaflet suture, with the leaflet suture extending proximally through the catheter. The leaflet suture is secured to the ventricular suture to limit a range of travel of the leaflet in the direction of the left atrium. Also disclosed is an assembled in situ mitral valve leaflet restraint, having a neo papillary muscle and a neo chordae tendinea.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: February 23, 2021
    Assignee: Pipeline Medical Technologies, Inc.
    Inventors: Gordon B. Bishop, Randall T. Lashinski, Erik Griswold
  • Publication number: 20200390554
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium. From an atrium side, a leaflet connector carried by a distal end of the catheter can be anchored to a superior surface of a mitral valve leaflet. A needle is axially advanceable through the leaflet connector and through the leaflet. A leaflet anchor having a leaflet suture can be advanced out of the needle to secure the mitral valve leaflet to the leaflet suture. A ventricular anchor is anchored to the wall of the ventricle to secure the ventricular wall to a ventricle suture. The leaflet suture and the ventricle suture may be tensioned and connected by a suture lock to form an artificial chordae.
    Type: Application
    Filed: May 21, 2020
    Publication date: December 17, 2020
    Inventors: Trung Ho Pham, Gordon B. Bishop, Erik Griswold, Stephen McDaniel, Cameron Paul Purcell
  • Publication number: 20200345496
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium, through the mitral valve, and into the left ventricle. A ventricular anchor is deployed from the catheter and into a wall of the left ventricle, leaving a ventricular suture attached to the ventricular anchor and extending proximally through the catheter. A leaflet anchor is deployed to secure a mitral valve leaflet to a leaflet suture, with the leaflet suture extending proximally through the catheter. The leaflet suture is secured to the ventricular suture to limit a range of travel of the leaflet in the direction of the left atrium. Also disclosed is an assembled in situ mitral valve leaflet restraint, having a neo papillary muscle and a neo chordae tendinea.
    Type: Application
    Filed: May 22, 2020
    Publication date: November 5, 2020
    Inventors: Gordon B. Bishop, Randall T. Lashinski
  • Publication number: 20200297489
    Abstract: Methods and devices for transvascular prosthetic chordae tendinae implantation are disclosed. A catheter is advanced into the left atrium. From an atrium side, the catheter can be anchored to a superior surface of a mitral valve leaflet and a leaflet anchor can be advanced into the mitral valve leaflet to secure the mitral valve leaflet to a leaflet suture. A ventricular anchor is anchored to the wall of the ventricle to secure the ventricular wall to a ventricle suture. The leaflet suture and the ventricle suture may be tensioned and connected by a suture lock to form an artificial chordae.
    Type: Application
    Filed: December 11, 2019
    Publication date: September 24, 2020
    Inventors: Gordon B. Bishop, Erik Griswold, Stephen R. McDaniel, Trung H. Pham, Cameron P. Purcell, Hien N. Lam
  • Patent number: 10682230
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium, through the mitral valve, and into the left ventricle. A ventricular anchor is deployed from the catheter and into a wall of the left ventricle, leaving a ventricular suture attached to the ventricular anchor and extending proximally through the catheter. A leaflet anchor is deployed to secure a mitral valve leaflet to a leaflet suture, with the leaflet suture extending proximally through the catheter. The leaflet suture is secured to the ventricular suture to limit a range of travel of the leaflet in the direction of the left atrium. Also disclosed is an assembled in situ mitral valve leaflet restraint, having a neo papillary muscle and a neo chordae tendinea.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: June 16, 2020
    Assignee: Pipeline Medical Technologies, Inc.
    Inventors: Gordon B. Bishop, Randall T. Lashinski
  • Patent number: 10675150
    Abstract: Methods and devices for transvascular prosthetic chordae tendinea implantation are disclosed. A catheter is advanced into the left atrium, through the mitral valve, and into the left ventricle. A ventricular anchor is deployed from the catheter and into a wall of the left ventricle, leaving a ventricular suture attached to the ventricular anchor and extending proximally through the catheter. A leaflet anchor is deployed to secure a mitral valve leaflet to a leaflet suture, with the leaflet suture extending proximally through the catheter. The leaflet suture is secured to the ventricular suture to limit a range of travel of the leaflet in the direction of the left atrium. Also disclosed is an assembled in situ mitral valve leaflet restraint, having a neo papillary muscle and a neo chordae tendinea.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: June 9, 2020
    Assignee: Pipeline Medical Technologies, Inc.
    Inventors: Gordon B. Bishop, Randall T. Lashinski